Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Reliable method detects finasteride in human plasma at low doses.

Ivermectin injections and spray, along with hygiene measures, successfully treated sarcoptic mange in guinea pigs.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Skin symptoms are common in lupus patients in Antananarivo.

Compound 7p shows strong potential as an anticancer agent.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

Early recognition and treatment of LPP can prevent hair loss and improve quality of life.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

Nanostructured lipid carriers can improve finasteride delivery for better hair loss treatment.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

Erlotinib can cause hair loss and texture changes.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Ruxolitinib cream may help treat severe hair loss in children.